Pricing
  1. US-listed companies
  2. Tonix Pharmaceuticals Holding Corp.
  3. Financials
  4. Accounts payable

Tonix Pharmaceuticals Holding Corp. (TNXP)

Market cap
$122.55M
P/E ratio
SummaryFinancials
Period EndAccounts payable (Million USD)YoY (%)
Dec 31, 20245+20.20%
Dec 31, 20234-53.12%
Dec 31, 20228-39.26%
Dec 31, 202113+188.86%
Dec 31, 20205+49.77%
Dec 31, 20193+136.88%
Dec 31, 20171+48.62%
Dec 31, 20161-71.40%
Dec 31, 20153+105.04%
Dec 31, 20141+94.38%
Dec 31, 20131

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat